Name: C15orf41 | Sequence: fasta or formatted (183aa) | NCBI GI: 14210512 | |
Description: hypothetical protein LOC84529 isoform 2
| Not currently referenced in the text | ||
Other entries for this name:
alt prot {281aa} hypothetical protein LOC84529 isoform 1 | |||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 4.9 9 1 C cysteine 4.4 8 2 D aspartate 6.6 12 1 E glutamate 7.1 13 2 F phenylalanine 4.4 8 1 G glycine 5.5 10 1 H histidine 5.5 10 2 I isoleucine 8.7 16 2 K lysine 3.8 7 1 L leucine 11.5 21 3 M methionine 1.1 2 1 N asparagine 3.8 7 1 P proline 4.9 9 2 Q glutamine 4.4 8 1 R arginine 4.4 8 1 S serine 5.5 10 1 T threonine 2.2 4 1 V valine 5.5 10 1 W tryptophan 2.2 4 1 Y tyrosine 3.8 7 1 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 hypothetical protein LOC84529 isoform 2 C15orf41 1.000 hypothetical protein LOC84529 isoform 1 PECAM1 0.014 platelet/endothelial cell adhesion molecule IFITM3 0.011 interferon-induced transmembrane protein 3 (1-8U) [... IFITM2 0.008 interferon induced transmembrane protein 2 (1-8D) [... MTMR4 0.008 myotubularin related protein 4 MPP3 0.008 palmitoylated membrane protein 3 KIAA0746 0.005 hypothetical protein LOC23231 PDE8A 0.005 phosphodiesterase 8A isoform 2 PDE8A 0.005 phosphodiesterase 8A isoform 1 ZMAT5 0.005 zinc finger, matrin type 5 ZMAT5 0.005 zinc finger, matrin type 5 POF1B 0.005 premature ovarian failure, 1BHuman BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.